Cell & Gene Therapy Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Prefilled Syringe, Infusion Bags), By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By Route of Administration (Oral, Intrav
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationCell & Gene Therapy Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Prefilled Syringe, Infusion Bags), By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By Route of Administration (Oral, Intrav
Global Cell & Gene Therapy drug Delivery Devices market is expected to show a robust growth in the forecast period, 2024-2028. This can be attributed to the growing use of cell and gene therapy for treatment of various chronic diseases such as cancer. The increasing demand for the drug delivery devices that are efficient in monitoring the drug dosage during the cell and gene therapies is expected to support the market growth in the coming years.
Cell and Gene Therapy is a transformative industry which is emerging with an efficient potential. The Cell and Gene therapy includes the extraction of cells, proteins or genetic material (DNA) from the Donor and altering them to provide highly specific and personalized therapy. The growing popularity of personalized medicine has significantly increased the demand for cell and gene therapies, thereby creating the demand for devices used to deliver these therapies.
The effective dosages help in maximizing the bioavailability of the drug at the target sites, making it convenient for the patients and thereby, actively supporting the growth of devices used for delivering different therapies including cell and gene therapies in the coming years. Novel drug delivery systems like subdermal implants found at in the market as variants such as rings and patches are anticipated to boost the global cell & gene therapy drug delivery devices market growth in the forecast period.
Increasing Prevalence of Chronic Diseases
10,065,305 are new cancer cases were reported among males and the most common type of cancer among them were Lung, Prostate, Colorectum, Stomach and Liver cancer. Similarly number of new cancer cases reported in female population were around 9,227,484; with breast cancer, colorectum cancer, lung cancer, cervix uteri and thyroid cancer being the most prevalent ones.
Growing number of FDA approvals regarding Cell and Gene Therapies & Clinical Trials
According to the Cell and Gene Journal, out of 22 cell and gene therapies approved by the FDA, 14 are cord blood-based treatments. The remaining approvals include two gene therapies, seven cell therapies and five modified cell therapies. Also, in total, cell & gene therapies account for just seven percent (7%) of the total 340 approved biologics. Also, of the over 50 total drugs approved by the FDA in 2021, only 2 were cell or gene therapies. Though it’s a small amount of the total approved drugs in 2021, it reflects that the approved cell and gene therapies grew by 10% which is a remarkable step in the development of medicine.
Increased Investment and Funding in the Cell and Gene Therapy Market
According to the Cell and Gene Journal, for gene therapy the investment growth rate from 2010 to 2021 has risen to 59%, whereas for cell therapy, the investment rate has grown to 63%
Also, the various Government of several countries is aiding the process of increasing awareness about the devices among the patients and doctors thereby supporting the Global Cell & Gene Therapy Drug Delivery Devices market growth.
Market Segmentation
Global Cell & Gene Therapy Drug Delivery Devices Market can be segmented by type, commercialized drugs, route of administration, method, and region
Market Players
Becton, Dickinson, and Company, Novartis AG, Amgen Inc., Kite Pharma, Inc., Pfizer, Inc., Bausch & Lomb Incorporated, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Orchard Therapeutics plc, Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation, are some of the leading players operating in the global cell & gene therapy drug delivery devices market.
| Attribute | Details |
| Base Year | 2022 |
| Historical Years | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · Type · Commercialized Drugs · Route pf Administration · Method |
| Regional Scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
| Country Scope | United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa |
| Key Companies Profiled | Becton, Dickinson, and Company, Novartis AG, Amgen Inc., Kite Pharma, Inc., Pfizer, Inc., Bausch & Lomb Incorporated, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Orchard Therapeutics plc, Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy